CPC A61K 31/519 (2013.01) [A61P 25/16 (2018.01); A61P 25/28 (2018.01)] | 12 Claims |
1. A method of treating a neurodegenerative disease, comprising the step of: administering trametinib to a patient diagnosed with the neurodegenerative disease,
wherein the neurodegenerative disease is selected from the group consisting of: dementia, vascular dementia, senile dementia, frontotemporal dementia, Lewy body dementia, Parkinson's disease, multiple system atrophy, corticobasal degeneration, progressive supranuclear palsy, Huntington's disease, and cerebellar ataxia.
|